3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
9
Multiple Myeloma
6
Glioma
6
Neoplasm Metastasis
5
Lymphoma
5
Hematologic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neurofibromatosis 1
4
Pancreatic Neoplasms
3
Neoplasms
3
Colorectal Neoplasms
3
Thyroid Neoplasms
2
Neurofibroma, Plexiform
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Juvenile
2
Glioblastoma
2
Brain Neoplasms
2
Astrocytoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Sarcoma
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
tislelizumab
3
toripalimab
1
tazemetostat
1
sintilimab
1
pembrolizumab
1
osimertinib
1
enzalutamide
1
envafolimab
1
WW Domain-Containing Oxidoreductase
1
Ultrasonography, Doppler
1
Ultrasonography
1
Specimen Handling
1
Radiotherapy
1
Oxaliplatin
1
Off-Label Use
1
Leucovorin
1
Injections
1
Indocyanine Green
1
Immune Checkpoint Inhibitors
1
Histocompatibility Testing
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumor
×
trametinib
×
90 days
×
Clear all
No trials found.